We subsequently evaluated endometrial GATA2 expression in the setting of common benign endometrial conditions associated with abnormal PGR activity including hormone-treated patients, peri/post-menopausal patients who have inactive endometrium, and in the setting of endometrial polyps. Here, GATA2 is linked to endometrial polyp.